Skip to content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues

BMC Cancer201717:892

https://doi.org/10.1186/s12885-017-3854-8

Received: 7 June 2017

Accepted: 28 November 2017

Published: 28 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
7 Jun 2017 Submitted Original manuscript
11 Aug 2017 Reviewed Reviewer Report - Neelam Bhardwaj
13 Aug 2017 Reviewed Reviewer Report - Kunle Odunsi
7 Sep 2017 Author responded Author comments - Victor Jaravine
Resubmission - Version 2
7 Sep 2017 Submitted Manuscript version 2
22 Nov 2017 Author responded Author comments - Victor Jaravine
Resubmission - Version 3
22 Nov 2017 Submitted Manuscript version 3
Publishing
28 Nov 2017 Editorially accepted
28 Dec 2017 Article published 10.1186/s12885-017-3854-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Bioinformatics, Wissenschaftszentrum Weihenstephan, Technische Universität München, Freising, Germany
(2)
Medigene Immunotherapies GmbH, a subsidiary of Medigene AG, Planegg, Germany
(3)
St Petersburg State Polytechnical University, St Petersburg, Russia

Advertisement